Phase I Clinical Trial to Evaluate the Safety of Baricitinib to Prevent Respiratory Insufficiency Progression in Oncohematological Patients Affected with COVID-19 - BARCOVID19 Study
Blood
; 140:10750-10751, 2022.
Article
in English
| ScienceDirect | ID: covidwho-2120347
Full text:
Available
Collection:
Databases of international organizations
Database:
ScienceDirect
Type of study:
Experimental Studies
/
Prognostic study
/
Randomized controlled trials
Language:
English
Journal:
Blood
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS